Skip to main content

Table 3 Univariate and multivariate survival analysis for recurrence-free survival

From: Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study

Variables

Univariate analysis

Multivariate analysis

P-value

Hazard ratio (95% CI)

P-value

Hazard ratio (95% CI)

Age

(1-year increase)

0.756

1.005 (0.973–1.038)

  

Sex

Woman

Reference

1.000

  
 

Man

0.544

0.801 (0.391–1.640)

  

Tumor location

Left colon

Reference

1.000

  
 

Right colon

0.480

1.320 (0.611–2.855)

  
 

Rectum

0.578

1.371 (0.451–4.167)

  

Serum CEA level

< 5 ng/ml

Reference

1.000

  
 

≥ 5 ng/ml

0.088

1.869 (0.912–3.828)

  

Tumor size

(1 cm increase)

0.102

1.077 (0.880–1.354)

  

Tumor grade

Low-grade

Reference

1.000

  
 

High-grade

0.777

1.149 (0.439–3.005)

  

Lymphovascular invasion

Absent

Reference

1.000

  
 

Present

0.080

1.388 (0.938–2.338)

  

TNM stage

Stage I-II

Reference

1.000

Reference

1.000

 

Stage III-IV

0.015

2.554 (1.195–5.460)

0.031

2.341 (1.079–5.078)

Adjuvant therapy

No

Reference

1.000

  
 

Yes

0.201

0.556 (0.226–1.367)

  

Maximum SUV

(1.0 increase)

0.075

1.041 (0.980–1.102)

  

MTV

(10.0 cm3 increase)

0.425

1.054 (0.926–1.200)

  

TLG

(10.0 g increase)

0.617

0.999 (0.986–1.013)

  

Mean SUV

(1.0 increase)

0.185

0.884 (0.767–1.017)

  

Median SUV

(1.0 increase)

0.089

1.009 (0.974–1.045)

  

CoV SUV

(0.10 increase)

0.031

0.503 (0.269–0.942)

0.019

0.484 (0.263–0.889)

Kurtosis

(1.0 increase)

0.930

1.018 (0.682–1.521)

  

Skewness

(1.0 increase)

0.811

1.151 (0.365–3.624)

  

Entropy

(1.0 increase)

0.433

1.277 (0.693–2.530)

  

Uniformity

(0.10 increase)

0.050

0.416 (0.173–1.000)

0.664

0.984 (0.290–3.653)

BM SUV

(1.0 increase)

0.221

1.646 (0.742–3.652)

  

BLR

(1.0 increase)

0.044

5.128 (1.030–23.282)

0.261

2.870 (0.456–18.049)

Spleen SUV

(1.0 increase)

0.293

1.766 (0.612–5.098)

  

SLR

(1.0 increase)

0.005

45.21 (3.212–636.387)

0.020

24.901 (1.660–373.709)

  1. BLR, bone marrow-to-liver uptake ratio; BM, bone marrow; CEA, carcinoembryonic antigen; CI, confidence interval; CoV, coefficient of variation; MTV, metabolic tumor volume; SLR, spleen-to-liver uptake ratio; SUV, standardized uptake value; TLG, total lesion glycolysis